Literature DB >> 10958867

Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy.

K Komosinska-Vassev1, K Olczyk, E J Kucharz, C Marcisz, K Winsz-Szczotka, A Kotulska.   

Abstract

Free radical-mediated oxidative stress has been implicated in the etiopathogenesis of several autoimmune disorders. We investigated the prooxidant-antioxidant status in order to evaluate the possible deleterious role of oxidative phenomena in patients with Graves' disease. Thirty patients with hyperthyroidism due to Graves' disease were investigated. Thirty age-matched healthy subjects were studied as a control group. Free radical activity indices, antioxidant defense systems, and thyroid and pituitary hormone levels were measured in fasting blood samples. Blood samples were taken before initiation of therapy and after attainment of euthyroid state. A significant increase in lipid peroxidation activity indices, i.e., conjugated dienes and thiobarbituric acid-reacting substances, was found in blood serum of the patients with untreated Graves' disease. These changes were accompanied by a decrease in plasma thiol and erythrocyte lysate thiol groups concentrations. Hyperthyroidism resulted in a marked increase in intracellular antioxidant enzymes, i.e., superoxide dismutase, catalase and glutathione peroxidase activities as compared to the controls. Extracellular anti-free radical scavenging systems potential, measured by glutathione reductase activity and total antioxidant status level, was found to be significantly decreased in untreated Graves' patients. Treatment with thiamazole resulted in normalization of the free radical and antioxidant activity indices. The obtained results indicate an enhanced generation of reactive oxygen species and impairment of cellular and extracellular antioxidant systems potential in patients with Graves' disease. The attainment of euthyroid state led to an improvement in oxidative stress indices and antioxidant potential parameters.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958867     DOI: 10.1016/s0009-8981(00)00306-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  20 in total

1.  Evaluation of oxidative status in patients with hyperthyroidism.

Authors:  Mehmet Aslan; Niyet Cosar; Hakim Celik; Nurten Aksoy; Ahmet Cumhur Dulger; Huseyin Begenik; Yasemin Usul Soyoral; Mehmet Emin Kucukoglu; Sahbettin Selek
Journal:  Endocrine       Date:  2011-04-26       Impact factor: 3.633

2.  Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy.

Authors:  Murat Kaçmaz; Murat Atmaca; Ayşe Arslan; Halit Demir; Mehmet Fatih Özbay
Journal:  Endocrine       Date:  2014-04-24       Impact factor: 3.633

3.  Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.

Authors:  M Leo; L Bartalena; G Rotondo Dottore; E Piantanida; P Premoli; I Ionni; M Di Cera; E Masiello; L Sassi; M L Tanda; F Latrofa; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2016-10-12       Impact factor: 4.256

Review 4.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

5.  Oxidative stress in graves' disease.

Authors:  Claudio Marcocci; Marenza Leo; Maria Antonietta Altea
Journal:  Eur Thyroid J       Date:  2012-06-07

6.  Relationship of hemoxygenase-1 and prolidase enzyme activity with oxidative stress in papillary thyroid cancer.

Authors:  D Terzioglu; S Teksoz; A E Arikan; E Uslu; E Yılmaz; B Eren
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

7.  Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity?

Authors:  C Duthoit; V Estienne; A Giraud; J M Durand-Gorde; A K Rasmussen; U Feldt-Rasmussen; P Carayon; J Ruf
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

8.  Oxidative Stress in Graves Disease and Graves Orbitopathy.

Authors:  Giulia Lanzolla; Claudio Marcocci; Michele Marinò
Journal:  Eur Thyroid J       Date:  2020-11-20

9.  Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.

Authors:  C De Ciuceis; A Pilu; C Cappelli; E Porteri; F Zani; A Santoro; E Gandossi; G E M Boari; N Rizzardi; M Castellano; D Rizzoni; E Agabiti Rosei
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

10.  Erythrocyte osmotic fragility and lipid peroxidation in experimental hyperthyroidism.

Authors:  Rıfat Yücel; Semra Ozdemir; Nuran Darıyerli; Selmin Toplan; M Can Akyolcu; Günnur Yiğit
Journal:  Endocrine       Date:  2009-10-23       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.